Site-Specific Photoaffinity Bioconjugation for the Creation of 89Zr-Labeled Radioimmunoconjugates

[1] Rudnick SI(2009)Affinity and avidity in antibody-based tumor targeting Cancer Biother Radiopharm 24 155-161

[2] Adams GP(2018)Understanding the in vivo fate of radioimmunoconjugates for nuclear imaging J Labelled Comp Radiopharm 61 672-692

[3] Vivier D(2009)Antibodies and Antimatter: The resurgence of immuno-PET J Nucl Med 50 2-5

[4] Sharma SK(2021)A systematic evaluation of antibody modification and (89)Zr-radiolabeling for optimized immuno-PET Bioconjug Chem 32 1177-1191

[5] Zeglis BM(2014)Enhanced immunoPET of ALCAM-positive colorectal carcinoma using site-specific (64)Cu-DOTA conjugation Protein Eng Des Sel 27 317-324

[6] Wu AM(2015)Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development Bioconjug Chem 26 176-192

[7] Sharma SK(2010)Site-specific and stoichiometric modification of antibodies by bacterial transglutaminase Angew Chem Int Ed Engl 49 9995-9997

[8] Glaser JM(2020)Site-specific (89)Zr- and (111)In-radiolabeling and in vivo evaluation of glycan-free antibodies by azide-alkyne cycloaddition with a non-natural amino acid Bioconjug Chem 31 1177-1187

[9] Edwards KJ(2016)Site-specifically labeled immunoconjugates for molecular imaging – Part 1: Cysteine residues and glycans Mol Imaging Biol 18 1-17

[10] Tavaré R(2016)Site-specifically labeled immunoconjugates for molecular imaging – Part 2: Peptide tags and unnatural amino Acids Mol Imaging Biol 18 153-165

[1] Rudnick SI(2009)Affinity and avidity in antibody-based tumor targeting Cancer Biother Radiopharm 24 155-161

[2] Adams GP(2018)Understanding the in vivo fate of radioimmunoconjugates for nuclear imaging J Labelled Comp Radiopharm 61 672-692

[3] Vivier D(2009)Antibodies and Antimatter: The resurgence of immuno-PET J Nucl Med 50 2-5

[4] Sharma SK(2021)A systematic evaluation of antibody modification and (89)Zr-radiolabeling for optimized immuno-PET Bioconjug Chem 32 1177-1191

[5] Zeglis BM(2014)Enhanced immunoPET of ALCAM-positive colorectal carcinoma using site-specific (64)Cu-DOTA conjugation Protein Eng Des Sel 27 317-324

[6] Wu AM(2015)Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development Bioconjug Chem 26 176-192

[7] Sharma SK(2010)Site-specific and stoichiometric modification of antibodies by bacterial transglutaminase Angew Chem Int Ed Engl 49 9995-9997

[8] Glaser JM(2020)Site-specific (89)Zr- and (111)In-radiolabeling and in vivo evaluation of glycan-free antibodies by azide-alkyne cycloaddition with a non-natural amino acid Bioconjug Chem 31 1177-1187

[9] Edwards KJ(2016)Site-specifically labeled immunoconjugates for molecular imaging – Part 1: Cysteine residues and glycans Mol Imaging Biol 18 1-17

[10] Tavaré R(2016)Site-specifically labeled immunoconjugates for molecular imaging – Part 2: Peptide tags and unnatural amino Acids Mol Imaging Biol 18 153-165